We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Prokarium Receives £2M to Develop Vaccines

News   Jul 28, 2016

 
Prokarium Receives £2M to Develop Vaccines
 
 
Advertisement
 

RELATED ARTICLES

mRNA COVID-19 Vaccine Is Well-Tolerated and Generates Immune Response

News

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.

READ MORE

Large Study Finds HPV Vaccine Is Effective Against Cervical Cancer

News

Women vaccinated against HPV have a significantly lower risk of developing cervical cancer, and the positive effect is most pronounced for women vaccinated at a young age. That is according to a large study by researchers at Karolinska Institutet in Sweden.

READ MORE

BCG Vaccine Does Not Protect Against COVID-19, Data Suggests

News

Using information from the Swedish public health agency, researchers determined that BCG vaccination during infancy actually does not protect against the SARS-CoV-2 virus.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE